You are here

  • Home
  • Archive
  • Volume 81, Issue 6
  • Testing for Neisseria gonorrhoeae by nucleic acid amplification testing of chlamydia samples using Roche Cobas Amplicor in a rural area in the north of England does not find more gonorrhoea in primary care

Article Text

Article menu
Download PDFPDF
Letter
Testing for Neisseria gonorrhoeae by nucleic acid amplification testing of chlamydia samples using Roche Cobas Amplicor in a rural area in the north of England does not find more gonorrhoea in primary care
  1. B Stanley,
  2. A Todd
  1. North Cumbria Acute Hospitals NHS Trust, Cumberland Infirmary, Carlisle CA2 7HY, UK
  1. Correspondence to:
 Dr Belinda Stanley
 North Cumbria, North Cumbria Acute Hospitals NHS Trust, Cumberland Infirmary, Carlisle CA2 7HY, UK; b.stanley{at}ukonline.co.uk

https://doi.org/10.1136/sti.2004.013722

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Men with urethral gonorrhoea are usually symptomatic, women are less likely to have symptoms.1,2 If women are tested only for chlamydia and found to be negative, and tests for Neisseria gonorrhoeae are not performed, they are at risk of continuing infection with N gonorrhoeae as the infections may occur together.3 Patients concerned that they may have a sexually transmitted infection may access care through their general practitioner (GP). When testing both symptomatic and asymptomatic patients for chlamydia, GPs do not always test for N gonorrhoeae (local laboratory data). Even if they did, problems with sample transport, storage, etc, may influence sensitivity of cultures.4,5

    To assess the effect of the introduction of …

    View Full Text